Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance

NEXT STORY
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
PREV STORY
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ovid Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Capricor Therapeutics Announces Key Updates on its Vaccine and Therapeutic Programs for COVID-19

author_avatar
NASDAQ Market News

Precision BioSciences to Present at Guggenheim Healthcare Talks 2021 Oncology Day

author_avatar
NASDAQ Market News